SkinKandy Limited · ASX:SK1
SkinKandy — Shareholder Meeting (November 2026)
21 slides from SkinKandy's shareholder meeting presentation, Nov 19, 2026
Slide 1: 2026 Annual General Meeting Presentation
SkinKandy. SKINKANDY LIMITED ABN 80 636 484 814 ASX RELEASE 19 November 2026 2026 Annual General Meeting Presentation SkinKandy Limited (“SkinKandy”, ASX: SK1) attaches the AGM Presentation to be delivered at the 2026 Annual General Meeting, scheduled for 10.00am (Sydney time) today. Included in the
Slide 2: Annual General Meeting 2026
SkinKandy. ANNUAL GENERAL MEETING 2026 THURSDAY 19 NOVEMBER 2026
Slide 3: Board and attendees
Board and attendees if tf Trent Peterson > Independent Non-Executive Chair ALSO ATTENDING Melanie Wilson ficer and Independent Non-Executive Director; Chair, Audit and Risk mittee Renee Jones Indep: Director dent Non-Executive SkinKandy. Richard Whiteoak Non-Executive Director Mark Oliphant Non-Exec
Slide 4: Questions and voting
Questions and voting Questions Shareholders, proxies, attorneys and corporate representatives may ask questions when invited by the Chair Raise your voting card and wait for a microphone State your name and whether you are a shareholder or proxy Please direct questions to the Chair and keep them bri
Slide 5: Chair's Address
For personal use only SkinKandy. Trent Peterson - Independent Non-Executive Chair CHAIR’S ADDRESS
Slide 6: FY26 results
CEO’S ADDRESS - DAIN FRIIS FY26 results Astrong first year as a listed company: ahead of Prospectus forecast on every key measure Revenue $90.2m Up 29%; 2% ahead of forecast Studios 109 22 opened; one ahead of forecast LFL growth 9.6% Prospectus forecast 8.1% Cash conversion 101% FY25: 92' 's is set
Slide 7: Growth strategy update
CEO'S ADDRESS - DAIN FRIIS Growth strategy update Strategy unchanged from the Prospectus. All three growth drivers are delivering in FY27. 1 ON TRACK Expand the network across Australia and New Zealand What we said: build towards 180 to 210 studios, with disciplined site selection UPDATES. + Opened
Slide 8: International expansion: phased plan and progress
CEO'S ADDRESS - DAIN FRIIS. International expansion: phased plan and progress Phasing unchanged. South Africa well progressed as our potential first market beyond ANZ, working towards first studios in H2 FY27. PHASE 1 ANZ home market + Network of 118 studios at the AGM date, targeting 180 to 210 at
Slide 9: Trade update and outlook
SkinKandy. Trade update and outlook Strong momentum maintained, with revenue up 21% in the first 19 weeks of FY27 (to 14 November 2026). ‘st 19 weeks of FY27 (to 14 November 2026) and outlook FY27 outlook statements Statu: Revenue growth expected to continue, supported by the roll-out and maturation
Slide 10: Notice of Meeting
‘SkinKandy. Notice of Meeting Dated 16 October 2026 - Returning Officer: Graham Butcher, MUFG Corporate Markets Item 1 Annual Financial Report No vote Resolution 1 Adoption of Remuneration Report Advisory Resolution 2 Election of Trent Peterson Ordinary Resolution 3 Election of Dain Friis Ordinary R
Slide 11: Item - Annual Financial Report
SkinKandy. No VOTE Item 1 - Annual Financial Report To receive and consider the Financial Report of the Company and its controlled entities, and the reports of the Directors and auditor, for the period ended 4 July 2026. + The reports form part of the 2026 Annual Report, available on our investor re
Slide 12: Resolution 1 - Adoption of Remuneration Report
‘SkinKandy. ADVISORY RESOLUTION Resolution 1 -— Adoption of Remuneration Report ORDINARY RESOLUTION “That the Remuneration Report for the period ended 4 July 2026 be adopted.” + The Remuneration Report is set out on pages 29 to 49 of the 2026 Annual Report * The vote is advisory only and does not bi
Slide 13: Proxy results - Adoption of Remuneration Report
‘SkinKandy. Proxy results — Resolution 1 Adoption of Remuneration Report For Open! Against Abstain Total Votes (Shares) 90,187,173 2,199 10,000 609,286 90,199,372 % of votes cast 99.99% 0.00% 0.01% = 100%
Slide 14: Election and re-election of Directors
‘SkinKandy. ORDINARY RESOLUTIONS Resolutions 2 to 7 — Election and re-election of Directors Each an ordinary resolution, voted on separately - Profiles in the Notice of Meeting RESOLUTION 2 RESOLUTION 3 RESOLUTION 4 RESOLUTION 5 RESOLUTION 6 RESOLUTION 7 ELECTION ELECTION ELECTION RE-ELECTION ELECTI
Slide 15: Proxy results - Director resolutions
Proxy results — Resolutions 2 to 7 Percentage of votes cast Resolution For 2 - Election of Trent Peterson 91.58% 3 = Election of Dain Friis 100.00% 4 - Election of Renee Jones 100.00% 5 - Re-election of Mark Oliphant 100.00% 6 - Election of Melanie Wilson 100.00% 7 - Re-election of Richard Whiteoak
Slide 16: Resolution 8 - LTI grant of Performance Rights to Dain Friis
‘SkinKandy. ORDINARY RESOLUTION - ASX LISTING RULE 10.14 Resolution 8 - LTI grant of Performance Rights to Dain Friis ORDINARY RESOLUTION “That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of Performance Rights to Dain Friis under the Company’s Long Term Incent
Slide 17: Proxy results - LTI grant to Dain Friis
‘SkinKandy. Proxy results — Resolution 8 LTI grant of Performance Rights to Dain Friis For Open! Against Abstain Total Votes (Shares) 90,338,209 2,199 ie) 609,286 90,340,408 % of votes cast 100.00% 0.00% 0.00% = 100%
Slide 18: Resolution 9 - Appointment of KPMG as auditor
‘SkinKandy. ORDINARY RESOLUTION Resolution 9 —- Appointment of KPMG as auditor ORDINARY RESOLUTION “That in accordance with section 327B(1)(b) of the Corporations Act 2001 and for all other purposes, KPMG, having been nominated by a shareholder and consented in writing to acting in the capacity of a
Slide 19: Proxy results - Appointment of KPMG as auditor
Proxy results - Resolution 9 Appointment of KPMG as auditor For Votes (Shares) 94,564,644 % of votes cast 100.00% Open’ 833 0.00% Against 1,366 0.00% ‘SkinKandy. Total 94,566,843 100%
Slide 20: Voting card and refreshments
For personal use only SkinKandy. Please hand your completed voting card to the MUFG Corporate Markets team. The poll closes 5 minutes after the close of the meeting. Please join the Directors and senior executives for light refreshments.
Slide 21: Disclaimer
Disclaimer Important information This presentation has been prepared by SkinKandy Limited (ABN 80 636 484 814) (Company) to provide summary information about the Company and its associated entities. The information in this presentation remains subject to change without notice. Except as required by